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Background: Femoro-femoral veno-arterial perfusion is an established circulatory support and cooling method for
thoracic- and/or thoracoabdominal aortic aneurysm repair. However, retrograde perfusion through femoral arteries can
lead to retrograde cerebral embolization and neurologic dysfunction after surgery. To avoid these complications, we have
established a femoro-femoral veno-venous perfusion technique and evaluated its safety and effectiveness in elective and
nonelective patients.
Methods: Common femoral veins were cannulated bilaterally percutaneously following systemic low-dose heparinization
(100 IU/kg body weight). Venous blood was drained from drainage of the inferior vena cava, and venous return followed
through the superior vena cava. After proximal aortic cross-clamping, veno-venous perfusion was switched to veno-
arterial antegrade perfusion through the distal descending thoracic aorta to achieve spinal and visceral perfusion or
through iliac arteries for distal perfusion combined with selective renovisceral blood perfusion. After completion of aortic
repair, the arterial cannula was removed and the patient rewarmed just by switching back to veno-venous perfusion. Gas
and temperature exchange as well as relevant hemodynamic parameters were recorded prospectively and analyzed
retrospectively in 25 consecutive patients including 15 nonelective cases.
Results: Percutaneous insertion of outﬂow (28F cannula) and inﬂow (18F cannula) venous cannulae was complication-free
and allowed unrestricted perfusion in all 25 patients. Veno-venous perfusion allowed effective cooling (mean body
temperature 36.6 6 0.6C to 31.6 6 2.1C, P [ .001 compared with start of cooling) and re-warming (mean body
temperature 30.5 6 3C to 36.3 6 0.8C, P [ .03 compared with start of re-warming). Hemodynamic as well as
pulmonary parameters remained remarkably stable during surgical dissection and single lung ventilation even in
nonelective cases. There was no complication associated with the perfusion technique during surgery.
Conclusions: Transfemoral veno-venous cooling and re-warming results in remarkable hemodynamic stability during open
repair of thoracic- and/or thoracoabdominal aortic aneurysms and eliminates the need for retrograde arterial perfusion
and its inherent risks. (J Vasc Surg 2013;58:33-41.)Maintaining adequate perfusion to the spinal cord and
to the visceral organs is critical in surgical repair of complex
thoracic aortic aneurysm (TAA) and thoracoabdominal
aortic aneurysm (TAAA).1 This is generally achieved by
using extracorporeal circulatory support with veno-arterial
perfusion and mild systemic hypothermia. Veno-arterial
perfusion is necessary to systemically cool down/rewarm
the patient and to maintain perfusion to the spinal cord,
the visceral organs, and the lower extremities once the
aorta is cross clamped. Perfusion is achieved through
femoro-femoral cannulation in a retrograde manner2
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ques and might result in retrograde cerebral embolization3
(Fig 2). To avoid the latter issue, perfusion is restricted to
the lower body (abdomen and legs), whereas the heart
pumps and maintains antegrade blood ﬂow to the supra-
aortic vessels. This perfusion technique is quite challenging
for the cardiopulmonaary bypass (CPB) technician, as he
has to maintain sufﬁcient cardiac output to avoid retro-
grade ﬂow from the femoral artery reaching the aortic
arch and brain. Typically, low cardiac output occurs
when the heart has to be pushed to the side to allow expo-
sure of the descending aorta or the aortic arch. Unfortu-
nately, a few seconds of insufﬁcient antegrade cardiac
output are sufﬁcient to allow retrograde ﬂow to reach the
brain. We present a new and original perfusion concept
that makes retrograde perfusion unnecessary and therefore
rules out the above-mentioned drawbacks completely.
METHODS
Study design and patient sample. Between March
2004 and August 2008, the femoro-femoral veno-venous
perfusion technique (VVPT) was applied in 25 patients
undergoing conventional open surgical repair of a TAA or33
Fig 1. Conventional veno-arterial femoral cooling as cooling and
rewarming method for open surgery in thoracoabdominal aortic
aneurysms (TAAAs). A limited retrograde ﬂow in the atheroscle-
rotic descending aorta in case of normal cardiac output is shown.
Fig 2. In case of reduced cardiac output because of surgical
manipulation or systemic hypotension, increased retrograde ﬂow
might lead to dislodging of unstable plaque material that causes
cerebral embolization.
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patients were treated with extracorporeal circulation and
mild systemic hypothermia. Patients were followed up until
February 2012. The records of 19male (76%) and six female
(24%) patients presenting with a mean age of 58.5 6 12.4
years (range, 29-77 years) were reviewed retrospectively by
the authors. Clinical condition, thoracic and thoraco-
abdominal aortic aneurysm pathologies according to the
Crawford classiﬁcation,4 surgical procedures, as well as
clinical outcome and complications are presented in the
Table. All patients underwent preoperative diagnostic
imaging including chest X-ray and thoracoabdominal
computed tomography angiography (Sensation 16;
Siemens, Erlangen, Germany). The study was approved by
the University of Zurich Ethics Committee.
Aortic pathologies. According to the Crawford classi-
ﬁcation of TAAAs,4 ﬁve patients had extent I, ﬁve patients
had extent II, seven patients had extent III, and six patients
had extent IV thoracic or TAAAs. In four cases, aortic
aneurysm extended to the aortic arch. Two patients
received a thoracoabdominal aortic replacement because of
occlusive aortic disease.Surgical technique. All surgical procedures were per-
formed under general anesthesia by two senior vascular
surgeons. Thoracic aortic and thoracoabdominal aortic
replacements including implantation of aorto-bi-iliac or
bifemoral Y grafts were performed according to standard
techniques. After induction of anesthesia and systemic low-
dose heparinization (bolus of 100 IU/kg body weight),
common femoral veins were cannulated percutaneously
bilaterally using the “Seldinger technique.” Venous
drainage was achieved by a 28F Fem-Flex II cannula
(Edwards Lifesciences, Irvine, Calif) introduced into the
infrarenal inferior vena cava. Venous blood was returned by
an 18F Fem-Flex II cannula (Edwards Lifescienes), which
was introduced via the opposite femoral vein into the
superior vena cava under continuous transesophageal
ultrasound monitoring (Fig 3). Using a heparin-coated tip-
to-tip system (Bioline; Jostra, Hirrlingen, Germany) with
5000 IU heparin in the CPB priming solution, perfusion
was initiated prior to thoracotomy or thoracoabdominal
incision. Cooling of patients to 32C was achieved using
a conventional cardiopulmonary bypass (Stöckert S III;
Stöckert, Munich, Germany) including an oxygenator
(Avant Physio; Dideco Stöckert, Munich, Germany).
Table. Clinical condition, disease extension, treatment, and outcome/complication(s) of 25 consecutive patients
receiving veno-venous cooling and rewarming on cardiopulmonary bypass
No. Condition
TAAA
crawford extent Procedure Outcome/complications
1 Symptomatic III VISC
Aorto-bifemoral graft
Bleeding, cardiac tamponade, stroke
Died on POD 1
2 Asymptomatic III ARCH
VISC
Aorto-bi-iliac graft
ICA
Pulmonary failure
3 Asymptomatic III-IV VISC
Aorto-bi-iliac graft
4 Symptomatic IV VISC
Aorto-bifemoral graft
5 Symptomatic (ChAD) II ARCH
VISC
Aortic tube graft
ICA and LA
Incomplete paraplegia (partially recovered),
left sided pleural effusion
6 Asymptomatic III VISC
Aortic tube graft
Incomplete paraplegia, temporary hemodialysis.
7 Symptomatic III VISC
Aortic tube graft
Bleeding, MOF, sepsis
Died on POD 9
8 Symptomatic III VISC
Aortic tube graft
9 Symptomatic VISC
Aorto-bifemoral graft
ICA
10 Asymptomatic IV VISC
Aortic tube graft
11 Asymptomatic IV VISC
Aortic tube graft
LA
Bleeding, ACS, respiratory failure
12 Symptomatic mycotic IV VISC
Aortic tube graft
13 Asymptomatic (ChAD) I Aortic tube graft
ICA
Temporary RL nerve injury
14 Asymptomatic (ChAD) I Aortic tube graft
15 Symptomatic (ChAD) II VISC
Aorto-bi-iliac graft
ICA and LA
Intractable bleeding
Died on table
16 Secondary AEF II Aortic tube graft Intractable sepsis/shock
Died 6 hours postoperatively
17 Symptomatic (ChAD) II VISC
Aortic tube graft
LA
Temporary renal failure
18 Asymptomatic IV VISC
Aorto bi-iliaco-femoral graft
Critical illness encephalopathy, MOF, sepsis
Died on POD 60
19 Ruptured I-III VISC
Aortic tube graft
Cardiopulmonary failure
Died on table
20 Symptomatic
(Takayasu’s arteritis)
II ARCH
Aortic tube graft
Temporary RL nerve injury.
TEVAR at eighth POD (anastomotic aneurysms)
21 Asymptomatic I Aortic tube graft
Renovisceral debranching
TEVAR
22 Asymptomatic (ChAD) I Aortic tube graft RL nerve injury, transient peripheral
sensory deﬁcit left foot
23 Ruptured IV VISC
Aortic tube graft
ECMO implantation
Ischemic encephalopathy
MOV
Died on POD 5
24 Secondary APF Aortic tube graft
25 Ruptured (Secondary AEF) III VISC
Aortic Xenografta
LA
Esophagectomy on POD 55
MOF, sepsis
Died on POD 81
ACS, Abdominal compartment syndrome;AEF, aorto-esophageal ﬁstula;APF, aorto-pulmonary ﬁstula; ARCH, aortic arch replacement (partial);ChAD, chronic
aortic dissection; ECMO, extracorporeal membrane oxygenation; ICA, intercostal artery; LA, lumbar artery;MOF, multi-organ failure; POD, postoperative day;
RL, recurrent laryngeal; TAAA, thoracoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic aneurysm repair; VISC, reimplantation of the reno-
visceral arteries.
aXenograft; Shelhigh Inc, Union, NJ.
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Fig 3. Veno-venous cooling and rewarming of patients was ach-
ieved by percutaneous insertion of a 28 F Fem-Flex II cannula into
the left common femoral vein (draining cannula positioned in the
infrarenal inferior vena cava) following systemic low-dose heparin-
ization (bolus of 100 IU/kg body weight). An 18 F Fem-Flex II
perfusion cannula was placed into the right common femoral vein
and positioned in the superior vena cava. Using a heparin coated
tip-to-tip system (5000 IU heparin in cardiopulmonary bypass
[CPB] priming solution) perfusion was initiated prior to thora-
cotomy or thoracoabdominal incision and patients were cooled.
Fig 4. After proximal aortic cross-clamping for thoraco-
abdominal aortic aneurysm repair (TEVAR), veno-venous perfu-
sion was switched to veno-arterial perfusion through common iliac
arteries combined with selective renovisceral blood perfusion. Both
venous cannulae served at this stage as draining cannulae. After
completion of aortic repair, the arterial cannulae were removed,
and patients were rewarmed by veno-venous perfusion.
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mL/min and inﬂow temperature was adjusted at
a minimum of 30C. Simultaneously, a left-sided thora-
cotomy for repair of a TAA or an antero-lateral thoraco-
abdominal incision for repair of a TAAA was performed.
Dissection of the distal aortic arch or the descending aorta
required single lung ventilation. Following proximal aortic
cross-clamping, veno-venous perfusion was switched to
veno-arterial perfusion after insertion of an 18F Fem-Flex II
cannula into the distal descending thoracic aorta or in case
of TAAA repair, into the iliac arteries combined with
selective renovisceral blood perfusion (Fig 4) to maintain
antegrade arterial perfusion during suturing the graft. At
this stage of the procedure, both venous cannulae served as
draining cannulae. When possible and/or necessary, the
aorta was clamped sequentially, and the intercostal arteries
were reimplanted selectively. Once repair of the aortic
pathology was completed, the arterial cannulae were
removed and patients were rewarmed by continuous veno-venous perfusion establishing a ﬂow rate between 1000 and
3000 mL/min and by adjusting temperature at a maximum
of 38C. Spinal ﬂuid drainage was used secondarily in two
patients developing signs of spinal cord ischemia. In four
patients, partial arch replacement was performed in addition
to thoracoabdominal aortic replacement.
Evaluated parameters. The aim of the study was to
assess technical feasibility as well as cooling and rewarming
efﬁciency of femoro-femoral VVPT. Furthermore, hemo-
dynamic and pulmonary stability were evaluated and
immediate technique related adverse effects were recorded.
To this end, rectal body temperature, heart rate, mean
arterial blood pressure, and central venous pressure were
recorded every 10 minutes before, during, and after
surgery. In addition, arterial and venous blood gases
(SaO2, pO2, pCO2, and pH) were taken and measured at
the same intervals. The rate of cooling was calculated and
presented as C/h to reach the target temperature of
32C. For rewarming, target temperature was deﬁned as
above 36C.
In addition to speciﬁc procedure related end points,
30-day mortality as well as postoperative complications
Fig 5. Veno-venous perfusion allowed effective cooling at 3.3C/h
using a ﬂow of 27636 780 mL/min (about 50% of cardiac output)
and gradient adjustment with a minimum temperature of 30C.
Target temperature was deﬁned as 32C or less. Changes in
temperaturewere signiﬁcant from10minonwards compared to start
of cooling (P ¼ .001, as indicated by *).
Fig 6. Hemodynamics cooling. Veno-venous cooling did not
inﬂuence hemodynamic and pulmonary stability as shown by heart
rate (HR), mean arterial pressure (MAP), oxygen saturation
(SaO2), and central venous pressure (CVP). During surgical
dissection of the proximal descending aorta and single lung
ventilation, additional oxygenation was achieved via the perfusing
cannula (extracorporeal membrane oxygenation).
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neurologic dysfunctions, the rate of postoperative
bleeding requiring revision, renal and pulmonary failure
requiring temporary hemodialysis, and reintubation were
recorded.
Statistical analysis. Laboratory data are given as
mean 6 standard deviation or as median and range in
case of nonparametric distribution of variables. Mortality
and complication rates are given in percent as well as the
absolute number compared with the total number of
patients because of the limited number of patients.
Student’s t-test was used to evaluate differences in temper-
ature, heart rate, blood pressure, and central venous pres-
sure within the same group. A P value of <.05 was
considered statistically signiﬁcant.
RESULTS
Procedure speciﬁc end points. Overall, there was no
VVPT-related complication at all. Percutaneous insertion
of cannulae was feasible and complication-free in all 25
patients. VVPT (mean blood ﬂow, 2763 6 780 mL/min)
allowed effective cooling. Within 90 minutes, mean body
temperature decreased from 36.6 6 0.6C to 31.6 6
2.1C (3.3C/h; P ¼ .001 from 10 minutes onward
compared with the start of cooling) (Fig 5). Moreover,
circulatory and pulmonary parameters remained remark-
ably stable during surgical dissection and single lung
ventilation (Fig 6). Mean arterial pressure during cooling
ranged between 69.8 6 8.6 mm Hg and 74.1 69.3 mm
Hg, and mean heart rate ranged between 64.9 6 15.2
bpm and 67.5 6 19.4 bpm. Mean oxygen saturation
during cooling was between 98.2% 6 2.2% and 98.9% 6
1.1% (all changes not signiﬁcant). Conversion to veno-
arterial perfusion and return to VVPT for rewarming was
uncomplicated in all 25 patients. Rewarming was equally
effective within 90 minutes and a mean blood ﬂow of
2962 6 870 mL/min; body temperature increased from
30.4 6 2.97C to 36.3 6 0.8C (3.9C/h; P ¼ .03 from
20 minutes onward) (Fig 7). Again, VVPT had no negative
effects on circulatory as well as pulmonary stability; mean
arterial pressure ranged between 69.9 6 5.9 mm Hg and
73.2 6 10.6 mm Hg, and mean oxygen saturation ranged
between 97.9 6 2.2 % and 98.8 6 1.7 % (not signiﬁcant)
(Fig 8). Only the mean heart rate increased signiﬁcantly at
rewarming by 34% from 65 6 15 bpm to 88 6 16 bpm
(P ¼ .01 from 40 minutes onward). Surgical repair of
descending aortic pathology took 210 minutes on average
(range, 80-570 minutes).
Procedure unrelated end points. Overall, 30-day
mortality was 24% (6/25 patients) and concerned only
nonelective patients, mostly salvage procedures (Table),
and not related to the VVPT. Two patients died intra-
operatively; one (patient 15) with acute aortic dissection
died from intractable coagulopathy and uncontrollable
bleeding from the extensive wound surface and the other
(patient 19) presenting initially with an acute cardiac
condition died from intractable heart failure because of
a ruptured TAAA after coronary angiogram. One patientdied because of multiorgan failure and sepsis on post-
operative day (POD) 9 (patient 7). Two patients (8%)
showed cerebral damage as extensive stroke and ischemic
encephalopathy and died on POD 1 and 5 (patient 1 and
23), respectively. Two patients (8%) showed signs of SCI,
of whom one (patient 5) showed a near complete recovery
of his paraparesis after cerebrospinal ﬂuid drainage,
whereas the other (patient 6) remained incomplete para-
plegic below L2 on follow-up until 5 years postoperatively.
Peripheral nerve injuries occurred in three patients (16%);
two of them with transient and one with persistent left
recurrent laryngeal nerve injury. Postoperative bleeding
requiring revision occurred in two patients (8%), renal
failure requiring temporary hemodialysis occurred in four
patients (16%), and pulmonary failure requiring reintuba-
tion occurred in three patients (12%). Overall, in-hospital
mortality was 32% as two additional patients (patients
18 and 25) died from multiorgan failure at POD 60
and 81.
Fig 7. Rewarming of patients was equally effective (3.9C/h)
using veno-venous perfusion at a ﬂow of 2962 6 870 mL/min
and gradient adjusted rewarming with a maximum blood
temperature of 38C. Target temperature was deﬁned as 36C and
above. Changes in temperature were signiﬁcant from 20 minutes
onward compared with start of rewarming (P ¼ .03, as indicated
by asterisks [*]).
Fig 8. Hemodynamics rewarming. Veno-venous rewarming had
no negative inﬂuence on hemodynamic and pulmonary stability as
shown by heart rate (HR), mean arterial pressure (MAP), oxygen
saturation (SaO2), and central venous pressure (CVP). HR
increased signiﬁcantly by 34.3% upon rewarming from 30.5C to
36.3C, but stayed within physiological limits (P ¼ .01 from 40
minutes onward compared with start of rewarming, as indicated by
asterisks [*]).
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Despite recent advances in surgical and anesthesiologic
management, open repair of thoracic and thoracoabdomi-
nal aneurysms is still associated with a considerable risk
for perioperative complications.5-8 Depending on the
extent and the nature of aortic pathology, patient comor-
bidities and perioperative management, mortality varies
between 5% and 24%, spinal cord ischemia leading to para-
paresis and paraplegia between 3.8% and 25%, and renal
failure requiring postoperative hemodialysis between 6%
and 18%. Several organ protective strategies such as cere-
brospinal ﬂuid drainage, reattachment of intercostal and
lumbar arteries, epidural cooling, motor evoked potential
monitoring, and hypothermic circulatory arrest have shown
positive results in terms of neuroprotection.6,9,10 Less
attention has been paid, however, to the importance ofdistal perfusion and improvements in cannulation and cool-
ing techniques and maintaining stable hemodynamics
during the procedure. Nevertheless, distal and lower
extremity perfusion has been described to increase hemo-
dynamic stability by the use of an aorto-iliac side arm
conduit in TAAA repair which limits ischemic time for
viscera, kidneys, and lower extremities.11 Similar results
with reduced morbidity have been obtained by the use of
a preliminary axillofemoral bypass.12 Antegrade perfusion
of the lower extremities may have a certain protective effect
against spinal cord ischemia through the perfusion of the
hypogastric arteries, which was suspected clinically already
in 1986.13 In combination with cerebrospinal ﬂuid
drainage, which has been shown to reduce paraplegia rate
in TAAA repair,6 distal aortic perfusion decreased SCI in
a series of descending TAA repair in 238 patients over
a period of 12 years to a rate of 1.3% 14 and has therefore
been proposed as another useful tool for the aortic
surgeon.15,16 Furthermore, renal dysfunction, which is
one of the common complications after TAAA repair, leads
to acute renal failure requiring hemodialysis in up to 18%.17
Pathopysiologically, ischemia during cross-clamping and
embolism of atherosclerotic debris were suspected to be
responsible for impairing renal function. Additionally,
myoglobin nephrotoxicity arising from leg ischemia caused
by femoral artery cannulation has been shown recently to
contribute to renal dysfunction after TAAA repair.18 This
report highlights the importance of avoiding peripheral
muscle ischemia leading to rhabdomyolysis19 and warrants
minimal ischemic time, peripheral perfusion, and less inva-
sive cannulation strategies. As a ﬁrst step, the beneﬁt of
a less invasive perfusion technique has already been shown
by the use of a nonocclusive femoral artery cannulation and
a heparin-coated minicircuit.20 This technique leads to
decreased ischemia and tissue damage, as shown by lower
creatine kinase and lactate dehydrogenase levels compared
with an occlusive cannulation control. Furthermore,
a recent experimental study proved that a low ﬂow,
moderate hypothermic (30C) lower body aortic perfusion
offers sufﬁcient microcirculation of the intestines.21
Complete avoidance of iliofemoral arterial occlusion during
the cooling period as well as avoidance of retrograde blood
ﬂow in the atheromatous abdominal aorta is achieved only
by veno-venous cannulation and perfusion. In this study, it
has been shown for the ﬁrst time that femoro-femoral
VVPT is an effective and safe method for cooling and
rewarming patients requiring surgery of TAA and TAAA
with CPB support. Feasibility of veno-venous cooling as
a therapeutic modality to achieve controlled moderate
hypothermia has been described in animals22,23 as well as
in a human study.24 However, cooling and rewarming efﬁ-
ciency in patients undergoing open thoracic aortic surgery
has not been evaluated up to now. Using a high ﬂow (2.76
L/min) and low gradient (minimum temperature of 30C)
volume-preserving perfusion technique, including
adequate cannulae sizes, a cooling rate of 3.3C/h was
achieved. This result is in excellent agreement with the
study of Piepgras et al, who induced moderate
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therapy with veno-venous bypass in seven patients with
severe head injuries.24 Using a nongradient adjusted
extracorporeal blood temperature of 28C to 30C and
a ﬂow rate of 200 mL/min, a cooling rate of 3.5C/h
was reported. However, a minimal blood temperature
difference as used in our study has been shown to be
beneﬁcial to avoid the negative hemodynamic effects re-
ported by others. In human-sized swine, a cooling rate
of up to 8.2C/h was achieved using a venous inﬂow
temperature of 4C at a ﬂow rate of 300 mL/min, but
at the expense of signiﬁcant bradycardia and hypoten-
sion.23 Similarly in dogs, a rapid cooling rate of 0.4C/
min using 400 mL/min of blood at 6.2C was reported
to produce hemodynamic instability caused by supraven-
tricular extrasystoles.22
In contrast and because of the high ﬂow, the low-
gradient volume-preserving perfusion technique demon-
strated remarkable hemodynamic stability in our series of
25 patients. Using this protocol, we did not see any severe
cardiac arrhythmias, and therefore, immediate full circula-
tory support, which would be provided by veno-arterial
perfusion, was not necessary. The critical importance of
intra- and postoperative hemodynamic stability to avoid
spinal cord ischemia has been shown in animals25 as well
as in humans.26 Finally, instability has been described as
an independent risk factor for paraplegia following repair
of TAAA.27
Furthermore, theVVPTprovided remarkablepulmonary
stabilitywithoxygen saturations of above98%during thoracic
aortic dissection and single lung ventilation. This was
achieved by additional oxygenation of the returning blood
during cooling, which provided adequate tissue and cardiac
oxygenation contributing further to hemodynamic stability.
As a perfusion method for extracorporeal membrane
oxygenation for patients in respiratory failure, veno-venous
perfusion is well established.28,29
Veno-venous rewarming was equally effective with an
increase of 3.9C/h using a ﬂow rate of 3.0 L/min and
gradient adjusted rewarming at a maximum of 38C.
Haughn et al reported on a similar rewarming rate of
3.4C/h in a hypothermic canine model with a veno-
venous ﬂow rate of 300 mL/min and a blood temperature
of 40C.30 Similar to the increase in heart rate of 34%
observed in our patients upon rewarming from 30.4C to
36.3C, they reported a 40% increase of heart rate upon
rewarming in hypothermic dogs.30
Technically, percutaneous insertion of femoral venous
cannulae using the “Seldinger-technique” proved to be
a safe and effective vascular access as described by others.24
Unlike veno-arterial perfusion techniques, which carry
a higher risk of vascular complications,31 veno-venous
perfusion has been shown to reduce vascular access-related
complications.32 Furthermore, by the use of a heparin-
coated perfusion system, only low dose systemic heparin-
ization is required. This has been shown to reduce the
amount of blood loss33 and, therefore, the need of blood
transfusions postoperatively after cardiac surgery.34Using this technique, femoral arterial cannulation and
retrograde perfusion can be completely avoided with its
inherent risk of thrombosis and/or antegrade embolization
into peripheral arteries, as well as retrograde cerebral and
visceral embolization caused by mobilization of unstable
plaque material. Retrograde cerebral embolization of
atheroma, clots and other atheroembolic material has
been suspected by Svensson et al to account for a greater
risk of stroke in patients undergoing ascending aortic and
aortic arch operations with concurrent thoracic, thoraco-
abdominal, and abdominal aortic aneurysms using the
femoral arterial cannulation technique.3,35,36 Since the
aorta has been recognized as the most severe site of athero-
sclerosis and the descending thoracic aorta in particular as
the site of most common mobile plaque,37 patients should
beneﬁt from avoiding retrograde ﬂow and mobilization of
these plaques. Direct evidence of retrograde cerebral
embolization of unstable descending aortic plaque material
downstream of the cerebral vessels during diastole in
atherosclerotic patients has been provided recently by
four-dimensional magnetic resonance imaging studies.38
Therefore, in a large cohort of patients, the overall stroke
rate of 3.5% to 6.7% using conventional perfusion methods
for the open repair of descending aortic pathology3,39 should
be positively inﬂuenced by the VVPT, although this remains
to be conclusively proven. Our study was designed to show
feasibility and effectiveness of veno-venous cooling/
rewarming and to demonstrate increased hemodynamic
stability, based on intraoperative parameters.
As there was no VVPT-related complication in any
patient, overall clinical outcome is considered as irrelevant
for the feasibility and safety study presented here. To inves-
tigate the potential of VVPT, all kinds of clinical presenta-
tions (elective, acute, and salvage procedures, respectively)
were included in this feasibility and safety study. Despite
the resulting quite heterogeneous population, temperature
and gas exchanges, as well as hemodynamic behaviors with
VVPT remained extremely constant throughout all
patients. The overall in-hospital mortality rate of 32%
results from a zero mortality rate in 10/10 elective aortic
repair cases, and a 53% mortality rate in acute repair of
ruptured aneurysm (two), ﬁstula (three), mycotic aneurysm
(one), and impending aortic rupture (nine). Results in the
latter 15 patients correspond to international results for
acute aortic pathologies.40
Limitations of our study include the retrospective study
design as well as the limited number of patients. This might
weaken any conclusions with respect to morbidity and
mortality advantages. However, the stability of hemody-
namic and pulmonary parameters intraoperatively is
certainly remarkable. A randomized, controlled clinical trial
including a larger number of patients will be needed to
prove deﬁnitively the noninferiority or even superiority of
VVPT compared with veno-arterial perfusion.
CONCLUSIONS
Veno-venous cooling and rewarming of patients
requiring conventional open repair of TAA/TAAA on
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in patients requiring moderate hypothermia. This new
technique has several major advantages compared with
the conventional veno-arterial perfusion technique. There
is no need for arterial perfusion to modify body tempera-
ture. Furthermore, oxygenation and hemodynamic param-
eters remain extraordinarily stable during perfusion, even
in acute cases. As a consequence, retrograde arterial perfu-
sion eventually leading to stroke and hemodynamic
instability associated with conventional veno-arterial
perfusion are completely ruled out. So far, this technique
can actually be considered as an attractive alternative to
conventional perfusion technique. As a future outlook,
comparative studies involving a larger cohort of patients
will be necessary to document clinical, especially neuro-
logic, beneﬁt. Finally, a further application of this new
VVPT may involve the rewarming of critically
hypothermic patients with residual cardiac activity.30AUTHOR CONTRIBUTIONS
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